These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9771451)

  • 1. Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas.
    Chetty R; Pillay P; Jaichand V
    J Clin Pathol; 1998 Jun; 51(6):477-8. PubMed ID: 9771451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature.
    Dermawan JK; Mukhopadhyay S; Shah AA
    Hum Pathol; 2019 Nov; 93():16-22. PubMed ID: 31442521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratins expression in paragangliomas of the cauda equina.
    Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
    Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.
    McNicol AM
    Endocr Pathol; 2006; 17(4):329-36. PubMed ID: 17525481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
    Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
    Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.
    Kumaki N; Kajiwara H; Kameyama K; DeLellis RA; Asa SL; Osamura RY; Takami H
    Endocr Pathol; 2002; 13(2):149-56. PubMed ID: 12165664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paragangliomas of the cauda equina have a distinctive cytokeratin immunophenotype.
    Orrell JM; Hales SA
    Histopathology; 1992 Nov; 21(5):479-81. PubMed ID: 1280616
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
    Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
    Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of endothelin-1, endothelin-3 and endothelin receptors in human pheochromocytoma and paraganglioma.
    Watanabe K; Hiraki H; Hasegawa H; Tanigawa T; Emura I; Honma K; Shibuya H; Fukuda T; Suzuki T
    Pathol Int; 1997 Aug; 47(8):540-6. PubMed ID: 9293534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study.
    Statuto M; Ennas MG; Zamboni G; Bonetti F; Pea M; Bernardello F; Pozzi A; Rusnati M; Gualandris A; Presta M
    Int J Cancer; 1993 Jan; 53(1):5-10. PubMed ID: 8380057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemodectoma of the cauda equina: case report.
    Ilgren EB; Teddy PJ
    Clin Neuropathol; 1984; 3(4):148-52. PubMed ID: 6090047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis.
    Achilles E; Padberg BC; Holl K; Klöppel G; Schröder S
    Histopathology; 1991 May; 18(5):453-8. PubMed ID: 1679411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.
    Lin WC; Chen SC; Chuang YT; Kuo KL; Huang KH
    Asian J Surg; 2011 Jan; 34(1):15-22. PubMed ID: 21515208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraganglioma of the cauda equina].
    Ugarte Elola AC; Hernández i Vidal A; Viladot i Pericé R; Royo i Salvador M; Pou i Serradell A
    Neurologia; 1993 Feb; 8(2):73-7. PubMed ID: 8383986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraganglioma of the cauda equina: a highly vascular tumour.
    Demirçivi Ozer F; Aydin M; Bezircioğlu H; Oran I
    J Clin Neurosci; 2010 Nov; 17(11):1445-7. PubMed ID: 20637630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
    Foo SH; Chan SP; Ananda V; Rajasingam V
    Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
    Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
    J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenteric Extra-adrenal Paraganglioma - An Unusual Cause of Intermittent Abdominal Pain.
    Stinson W; Bjordahl P
    S D Med; 2021 Aug; 74(8):376-379. PubMed ID: 34461004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.